Manufacturing and Production

Showing 15 posts of 5813 posts found.

Genuv partners with Aiforia for AI-Powered Drug Screening Platform

February 15, 2022 Manufacturing and Production

Genuv has announced an agreement with the medical technology company Aiforia Technologies, to add Aiforia’s AI deep learning for medical …

‘Game-changing’ South African mRNA hub set to be a foundation for self-reliance

February 15, 2022 Manufacturing and Production

WHO officials have visited a number of public and private sector partners that are collaborating to develop and build WHO’s …

Thermo Fisher Scientific partners with Medidata Acorn AI for clinical research advancement

February 8, 2022 Manufacturing and Production

Thermo Fisher Scientific has announced a multiyear partnership with medidata Acorn AI, a Dassault Systemes company leading the digital transformation …

Thousands with advanced prostate cancer to benefit from drug approval

February 8, 2022 Manufacturing and Production

Astellas has announced that the SMC has accepted the use of XTANDIâ„¢ (enzalutamide) to treat patients with metastatic hormone-sensitive prostate …

SMC approves diroximel fumarate as multiple sclerosis treatment

February 8, 2022 Manufacturing and Production

The SMC has approved VUMERITY (diroximel fumarate), a next-generation oral fumarate for the treatment of adults living with relapsing-remitting multiple …

First immunotherapy to treat advanced endometrial cancer on the NHS via Cancer Drugs Fund

February 8, 2022 Manufacturing and Production

GSK has shared that NICE is to issue a final appraisal determination (FAD) recommending the use of JEMPERLI®▼ (dostarlimab) via …

AI technology has the potential for breast cancer diagnosis

February 1, 2022 Manufacturing and Production

Academics at King’s College, London, and Guy’s and St Thomas’ NHS Foundation Trust, are using historical scans in a new …

WHO: COVID-19 hospital waste presents health threat

February 1, 2022 Manufacturing and Production

The vast amount of waste produced in tackling the COVID-19 pandemic poses a threat to human and environmental health, warns …

FDA grants Evrysdi priority review for treatment of spinal muscular atrophy in infants

January 25, 2022 Manufacturing and Production

The FDA has granted priority review of a supplemental new drug application (sNDA) for Evrysdi (risdiplam), to expand the indication …
credit_-_crevis_shutterstock_340710245_720

Significantly reduced tumour growth with new candidate

January 25, 2022 Manufacturing and Production

Spago Nanomedical AB announced new clinical and preclinical results for the company’s leading candidate drug, Tumorad® (177Lu-SN201). In a preclinical …

Bimzelx approved in Japan for treatment of multiple types of psoriasis

January 25, 2022 Manufacturing and Production

UCB announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted marketing authorisation for BIMZELX (bimekizumab) for …

FDA restrict use of two monoclonal antibody treatments

January 25, 2022 Manufacturing and Production

The FDA has shared that it is limiting the use of two monoclonal antibody therapies for the treatment of COVID-19, …

Julie Beeso joins Envision Pharma Group as new Global Director

January 18, 2022 Manufacturing and Production

Envision Pharma Group has appointed Julie Beeso as its Global Director, Professional Development and Engagement. Julie has worked for almost …
mario_torchia_ist

Mario Torchia appointed as new Vice President of Sales & Marketing at InSilicoTrials

January 18, 2022 Manufacturing and Production

InSilicoTrials, a leader in simulation software solutions for healthcare, has announced Mario Torchia’s appointment. Torchia recently led the Sales Strategy …

Enhertu granted priority review in US for patients with HER2-positive metastatic breast cancer

January 18, 2022 Manufacturing and Production

Enhertu, manufactured by AstraZeneca and Daiichi Sankyo, has been accepted for the treatment of adult patients in the US with …

Latest content